Amicus' (FOLD) AT-GAA Shows Clinically Meaningful & Significant Improvements in Both Musculoskeletal and Respiratory Measures in Late-Onset Pompe Disease Compared to Standard of Care in Pivotal Phase
Go back to Amicus' (FOLD) AT-GAA Shows Clinically Meaningful & Significant Improvements in Both Musculoskeletal and Respiratory Measures in Late-Onset Pompe Disease Compared to Standard of Care in Pivotal Phase| Amicus Therapeutics, Inc. (NASDAQ: FOLD) | Delayed: 10.61 +0.28 (2.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.33 | 52 Week High | $11.78 | |||
| Open | $10.27 | 52 Week Low | $4.98 | |||
| Day High | $10.66 | P/E | N/A | |||
| Day Low | $10.24 | EPS | $-1.15 | |||
| Volume | 2,501,716 | |||||
